Deborah M. Sharpe

Deborah M. Sharpe serves as a Contract Specialist at the Naval Medical Research Center (N32398), where she manages the acquisition of critical biomedical research and diagnostic technologies essential to force health protection. Her portfolio centers on supporting the agency’s mission to develop field-deployable medical solutions for U.S. Navy and Marine Corps personnel, with a focus on rapid diagnostics, laboratory instrumentation, and infectious disease detection systems. She executes complex procurements under FAR and DFARS guidelines, ensuring compliance with DoD standards while advancing innovation in austere-environment medical capabilities. Her work bridges scientific requirements with contractual execution, enabling timely delivery of mission-critical R&D and diagnostic tools. Sharpe maintains a primary contracting relationship with REES SCIENTIFIC CORPORATION, a trusted partner in the development and delivery of specialized biomedical research equipment and analytical systems. Her procurement patterns reflect a preference for established vendors with proven technical expertise in life sciences instrumentation and in-vitro diagnostic manufacturing. While she engages with a limited pool of high-capacity contractors, her engagements are characterized by long-term collaboration, technical alignment, and consistent performance, reflecting a focus on mission-critical reliability over broad vendor diversification. Her contracting activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a strategic prioritization of technical capability and operational readiness over socioeconomic preferences, consistent with the urgent, mission-driven nature of biomedical research for deployed forces. While small business participation is not formally structured into her acquisition strategy, her focus remains on securing the highest-performing solutions regardless of vendor size. Sharpe’s procurement activity is concentrated in NAICS 541712 (Research and Development in the Physical, Engineering, and Life Sciences), followed by 325413 (In-Vitro Diagnostic Substance Manufacturing) and 334516 (Analytical Laboratory Instrument Manufacturing). She routinely acquires advanced diagnostic platforms, laboratory analyzers, and field-deployable medical devices, demonstrating deep expertise in life sciences R&D, clinical diagnostics, and precision instrumentation procurement for military medical applications.